Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ObsEva SA (company was delisted NASDAQ) (OBSV)

  • Event
  • July 29, 2022, 11:06 UTC
  • 10
  • 1 comments

(99% Neutral) ObsEva SA (company was delisted NASDAQ) (OBSV) Announces Clinical Development Update (Form 6-K)

Comment Full text

ImmunoGen Inc (was acquired by AbbVie (NYSE: ABBV) on 12/02/2024) (IMGN)

  • Event
  • July 29, 2022, 10:41 UTC
  • 13
  • 1 comments

(30% Negative) ImmunoGen, Inc. (IMGN) Reports Q3 2022 Financial Results

Comment Full text

AstraZeneca (AZN)

  • Event
  • July 29, 2022, 10:18 UTC
  • 10
  • 1 comments

(99% Neutral) AstraZeneca (AZN) Announces 2022 Annual General Meeting

Comment Full text

NRx Pharmaceuticals Inc (NRXP)

  • Event
  • July 28, 2022, 21:02 UTC
  • 14
  • 1 comments

(99% Neutral) NRX PHARMACEUTICALS, INC. (NRXP) Announces Executive Departure

Comment Full text

Radius Health Inc (the company was acquired by Gurnet Point Capital (“Gurnet Point”) and Patient Square Capital (“Patient Sq (RDUS)

  • Event
  • July 28, 2022, 20:16 UTC
  • 13
  • 1 comments

(99% Neutral) RADIUS HEALTH, INC. (RDUS) Announces Regulatory Update

Comment Full text

Ultragenyx Pharmaceutical Inc (RARE)

  • Event
  • July 28, 2022, 20:09 UTC
  • 13
  • 1 comments

(10% Negative) Ultragenyx Pharmaceutical Inc. (RARE) Reports Q3 2022 Financial Results

Comment Full text

Seagen Inc (was acquised by Pfizer Inc. (NYSE: PFE) on 14/12/2023) (SGEN)

  • Event
  • July 28, 2022, 20:05 UTC
  • 13
  • 1 comments

(10% Negative) SEAGEN INC. (SGEN) Reports Q3 2022 Financial Results

Comment Full text

Gilead Sciences Inc (GILD)

  • Event
  • July 28, 2022, 20:01 UTC
  • 13
  • 1 comments

(99% Neutral) GILEAD SCIENCES, INC. (GILD) Announces Executive Changes

Comment Full text

Sanofi (SNY)

  • Event
  • July 28, 2022, 14:12 UTC
  • 10
  • 1 comments

(30% Negative) Sanofi (SNY) Reports Q2 2022 Financial Results (Form 6-K)

Comment Full text

TherapeuticsMD Inc (TXMD)

  • Event
  • July 28, 2022, 13:47 UTC
  • 13
  • 1 comments

(99% Neutral) TherapeuticsMD, Inc. (TXMD) Announces Clinical Development Update

Comment Full text
  • Previous
  • 146
  • 147
  • 148
  • 149
  • 150
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124508)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin